Brief: Charmacy Pharmaceutical Says Formal Approval From CSRC Received
06/06/2022 15:42
June 6 (Reuters) - Charmacy Pharmaceutical Co Ltd 2289.HK :
* FORMAL APPROVAL FROM CSRC ON APPLICATION REGARDING
IMPLEMENTATION OF H SHARE FULL CIRCULATION PROGRAMME RECEIVED
Source text for Eikon: ID:nHKS3r8hDz
Further company coverage: 2289.HK
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17